Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS · Delayed Price · Currency is USD
0.0171
0.00 (0.00%)
Apr 1, 2025, 4:00 PM EST

Emmaus Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Apr '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
1613826095
Upgrade
Market Cap Growth
-71.61%-52.02%-84.34%36.67%-36.90%-
Upgrade
Enterprise Value
3239421034277
Upgrade
Last Close Price
0.020.100.261.671.231.97
Upgrade
PE Ratio
----44.50-
Upgrade
Forward PE
--4.34---
Upgrade
PS Ratio
0.050.210.704.002.604.20
Upgrade
PB Ratio
-0.04-0.13-0.38-3.84-11.68-8.64
Upgrade
EV/Sales Ratio
1.581.312.274.991.823.40
Upgrade
EV/EBITDA Ratio
39.6310.85--1503.76-
Upgrade
EV/EBIT Ratio
1767.7310.95----
Upgrade
Debt / Equity Ratio
-0.60-0.68-0.90-1.04-3.68-1.76
Upgrade
Debt / EBITDA Ratio
27.506.89--15.45-
Upgrade
Asset Turnover
0.550.710.350.360.390.34
Upgrade
Inventory Turnover
0.660.660.760.580.300.17
Upgrade
Quick Ratio
0.100.130.040.090.120.97
Upgrade
Current Ratio
0.140.190.120.250.481.26
Upgrade
Return on Assets (ROA)
0.03%5.31%-7.84%-6.59%-0.03%-1.96%
Upgrade
Return on Capital (ROIC)
----51.80%-0.18%-10.70%
Upgrade
Earnings Yield
-320.12%-60.31%-82.36%-19.36%2.25%-57.43%
Upgrade
FCF Yield
-146.96%-24.56%-39.53%-1.61%-4.09%-4.80%
Upgrade
Buyback Yield / Dilution
-18.10%-7.41%-0.38%-0.73%-15.71%-14.66%
Upgrade
Updated Nov 19, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.